TY - CHAP
T1 - Endocrinologic issues
AU - Hu, Mimi I.
AU - Jimenez, Camilo
AU - Busaidy, Naifa L.
AU - Habra, Mouhammed Amir
N1 - Publisher Copyright:
© The University of Texas M.D. Anderson Cancer Center 2015.
PY - 2015/1/1
Y1 - 2015/1/1
N2 - This chapter outlines the important and common late-onset, long-term endocrine disorders that occur as a consequence of cancer therapy in survivors: bone metabolism disorders, metabolic (i.e., glucose and lipid) disorders, thyroid neoplasia and dysfunction, hypothalamic-pituitary dysfunction, adrenal dysfunction, and gonadal system disorders. Strategies for evaluating and managing these effects are included.
AB - This chapter outlines the important and common late-onset, long-term endocrine disorders that occur as a consequence of cancer therapy in survivors: bone metabolism disorders, metabolic (i.e., glucose and lipid) disorders, thyroid neoplasia and dysfunction, hypothalamic-pituitary dysfunction, adrenal dysfunction, and gonadal system disorders. Strategies for evaluating and managing these effects are included.
UR - http://www.scopus.com/inward/record.url?scp=84944533787&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84944533787&partnerID=8YFLogxK
U2 - 10.1007/978-1-4939-0986-5_21
DO - 10.1007/978-1-4939-0986-5_21
M3 - Chapter
AN - SCOPUS:84944533787
SN - 9781493909858
SP - 343
EP - 360
BT - Advances in Cancer Survivorship Management
PB - Springer New York
ER -